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Chlamydia pneumoniae has been associated to atherosclerotic cardiovascular diseases.
The aim of our study was to characterize, for the first time, aC. pneumoniae strain isolated
from the gingival crevicular fluid of a patient with chronic periodontitis, described as a
risk factor for cardiovascular diseases. C. pneumoniae isolate was characterized and
compared to the respiratory AR-39 strain by VD4-ompA genotyping and by investigating
the intracellular growth in epithelial and macrophage cell lines and its ability to induce
macrophage-derived foam cells. Inflammatory cytokine levels were determined in the
gingival crevicular fluid sample. C. pneumoniae isolate showed a 99% similarity with the
AR-39 strain in the VD4-ompA gene sequence and shared a comparable growth kinetic
in epithelial cells and macrophages, as evidenced by the infectious progeny and by the
number of chlamydial genomic copies. C. pneumoniae isolate significantly increased the
number of foam cells as compared to uninfected and LDL-treated macrophages (45
vs. 6%, P = 0.0065) and to the AR-39 strain (45 vs. 30%, P = 0.0065). Significantly
increased levels of interleukin 1-β (2.1 ± 0.3 pg/µL) and interleukin 6 (0.6 ± 0.08 pg/µL)
were found. Our results suggest that C. pneumoniae may harbor inside oral cavity and
potentially be atherogenic, even though further studies will be needed to clarify the
involvement of C. pneumoniae in chronic periodontitis as a risk factor for cardiovascular
diseases.
Keywords: Chlamydia pneumoniae, atherosclerotic cardiovascular diseases, chronic periodontitis, gingival
crevicular fluid, interleukin-1β, interleukin-6
INTRODUCTION
Chlamydia pneumoniae (C. pneumoniae) is an intracellular obligate pathogen with a unique
developmental cycle consisting of an extracellular infectious form (elementary body, EB)
responsible for transmitting the infection and an intracellular replicative form (reticulate body,
RB) responsible for growth and multiplication within host cell. A chlamydial persistent form has
recently been described as a strategy to escape the host immune response, resulting in a long-term
infection. Chlamydial persistent forms are viable but not infectious, as indicated by continuous
genomic DNA replication and reduced production of EBs (Schoborg, 2011; Di Pietro et al., 2012).
In the last two decades, C. pneumoniae, a common cause of respiratory tract infections, has
been widely associated with atherosclerosis, a chronic inflammatory disease of the vascular wall, by
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seroepidemiological studies, C. pneumoniae DNA detection
in the atherosclerotic plaque and by the isolation of viable
bacteria from the atheroma (Campbell and Rosenfeld, 2015).
C. pneumoniae persistent form is believed to mediate the
chronic inflammatory state, as evidenced by an increased
production of pro-inflammatory cytokines, contributing to
chronic inflammatory diseases such as cardiovascular diseases
(Atik et al., 2010; Campbell et al., 2010; Schoborg, 2011).
C. pneumoniae is presumed to play a role in the pathogenesis
of atherosclerosis for its ability to disseminate systemically
from the lungs through peripheral blood mononuclear cells
(PBMCs) and to localize in extra-pulmonary sites such as
the vascular wall (Moazed et al., 1998; Watson and Alp,
2008). Once inside the vascular tissue, C. pneumoniae has
been shown to induce endothelial dysfunction and low density
lipoprotein (LDL) oxidation, resulting in the accelerated uptake
of cholesterol by macrophages, and the subsequent foam cell
formation, considered as the hallmark of early atherosclerotic
lesions (Kalayoglu et al., 1999; He et al., 2009). C. pneumoniae
has also been demonstrated to contribute to platelet adhesion and
aggregation and smooth muscle cell proliferation and migration,
all events responsible for progression and rupture of vascular
lesion and, hence, for acute cardiovascular events (Di Pietro et al.,
2013a; Chatzidimitriou et al., 2014).
Several risk factors for atherosclerosis have been identified,
including traditional (smoking, hypertension, hyperlipidemia,
and diabetes) and non-traditional factors (inflammation,
oxidative stress, and infections; Balagopal et al., 2011; Di
Pietro et al., 2013a). Recently, chronic periodontitis has also
been described as a predisposing factor for atherosclerotic
cardiovascular diseases (Kholy et al., 2015). Indeed, it has been
reported that patients with chronic periodontitis have a 19%
greater risk of atherosclerotic cardiovascular disease than healthy
individuals (Kurita-Ochiai and Yamamoto, 2014).
Chronic periodontitis, an inflammatory disease of periodontal
tissue resulting from oral infections, is characterized by the
formation of a periodontal pocket where gingival crevicular
fluid drastically increases in response to oral pathogens,
resulting in local severe inflammation, and destruction of the
periodontium. The major pathogen responsible for periodontitis
is Porphyromonas gingivalis, known to cause gingival ulceration,
epithelial barrier destruction and, hence, to translocate into the
systemic circulation, contributing to endothelial dysfunction,
first step of the atherosclerotic process (Kebschull et al., 2010).
C. pneumoniae has also been suggested to harbor into
the oral cavity, since it has been shown to infect gingival
fibroblasts, resident cells of the periodontium, and to increase the
inflammatory state underlying chronic periodontitis (Rizzo et al.,
2008a,b).
Following the destruction of the periodontium, C.
pneumoniaemay enter the bloodstream,migrate into the vascular
wall and induce the production of circulating cytokines and
chemokines, contributing directly or indirectly to atherogenesis
and, hence, to atherosclerotic cardiovascular diseases.
Here we isolated and characterized, for the first time, a C.
pneumoniae strain from the gingival crevicular fluid of a patient
with chronic periodontitis via specific gene typing. Furthermore,
the phenotypical characteristics of C. pneumoniae clinical isolate
were also investigated, followed by a comparative analysis to the
reference strain AR-39.
MATERIALS AND METHODS
Gingival Crevicular Fluid and Peripheral
Blood Samples
Specimens of gingival crevicular fluid and peripheral blood
were obtained from a 61-year old man suffering from chronic
periodontitis diagnosed in accordance to the criteria proposed
by the 1999 International World Workshop for a Classification
of Periodontal Disease and Conditions (four sites with probing
pocket depth ≥ 6mm and attachment loss ≥ 4mm; Armitage,
1999).
The patient, referred to George Eastman Dental Hospital for
dental or periodontal treatment, received neither professional
cleaning nor antibiotic treatment in the last 6 months.
He was free from any cardiovascular and respiratory disease;
he was an ex-smoker and had hypertension, diabetes and a family
history of cardiovascular diseases.
A total of 16 gingival crevicular fluid samples, eight from
the deepest periodontal pocket and eight from four healthy
periodontal sites, were collected by using sterile paper strips
(#30PerioPaper). Before sampling, the sites for gingival crevicular
fluid collection were gently air-dried, isolated from saliva with
cotton rolls and the supra-gingival plaque was removed; then,
paper strips were inserted in the sites for 10 s. Four paper strips
were pooled in a sterile microcentrifuge tube containing sucrose-
phosphate-glutamate buffer (SPG, 0.2 mol/L sucrose, 3.8mmol/L
KH2PO4, 6.7mmol/L Na2HPO4, 5.5mmol/L glutamic acid at
pH 7.4) and four paper strips in a sterile microcentrifuge tube
containing phosphate buffered saline (PBS) for culture and real-
time PCR assays respectively. The ultimate volume of the pooled
gingival crevicular fluid samples from the diseased and healthy
sites were about 4 and 1.3µL, respectively. Strips contaminated
with blood were discarded and a new site was selected.
All gingival crevicular fluid samples were stored at −80◦C
until further processing.
Peripheral blood specimen (5mL) was used for the isolation of
PBMCs through Ficoll–Hypaque density gradient centrifugation.
Written informed consent was obtained from the patient and
the study was approved by the International Review Board of
“Sapienza” University of Rome.
C. pneumoniae DNA Detection by
Real-time PCR
Genomic DNA was extracted from 200µL of diluted gingival
crevicular fluid sample and from 106 PBMCs using the QIAamp
DNA Mini Kit (Qiagen) according to the manufacturer’s
instructions. C. pneumoniae AR-39 infected HEp-2 epithelial
cells (ATCC CCL 23) and mock-infected HEp-2 cells were used
as positive and negative extraction controls respectively.
Detection and quantification of C. pneumoniae DNA were
performed by real-time PCR targeting MOMP gene using the
Primerdesign™ genesig R© Kit according to the manufacturer’s
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instructions. Each PCR-run contained the PCR-negative control
(ultrapure water PCR grade) and positive and negative extraction
controls. DNA sample, positive and negative extraction controls
were analyzed in triplicate. The sample was considered positive
if all of three assay results were positive in the replicate
test.
C. pneumoniae Detection by Direct
Fluorescence Assay
The gingival crevicular fluid samples from the diseased and
healthy periodontal sites were centrifuged on cytoslide by
cytospin for 5min at 400 rpm (Thermo Scientific Cytospin
4, Thermo Fisher Scientific). Then, the cells were fixed
with methanol, and stained with fluorescein isothiocyanate
(FITC)-conjugated monoclonal antibody against chlamydial
lipopolysaccharide (Pathfinder Chlamydia Culture Confirmation
System, Biorad). The presence of C. pneumoniae inclusions was
determined by fluorescence microscope (400x magnification).
Isolation of C. pneumoniae
Clinical isolate was recovered in HEp-2 cells as previously
described by Dowell et al. (2001). Briefly, 200µL of diluted
gingival crevicular fluid sample was inoculated on HEp-2 cells
grown in 24-well plates in Dulbecco’s Modified Eagle’s medium
high glucose (DMEM, Euroclone, Italy) supplemented with
10% (v/v) fetal calf serum (FCS), 100µg/mL streptomycin,
250µg/mL amphotericin B, 1% non-essential amino acids, and
1% sodium pyruvate (complete growth medium). Infected HEp-
2 cells were centrifuged for 1 h at 1250 g at 37◦C, and then
incubated at 37◦C and 5% CO2 for 3 h. Infected cell monolayers
were then overlaid with complete growth medium supplemented
with 2% FCS and 1µg/mL cycloheximide, and incubated at
37◦C and 5% CO2 for 72 h. Then, infected cells were further
passaged to fresh HEp2 cell monolayers. In order to evaluate
the development of chlamydial inclusions, infected HEp-2 cells,
after each growth cycle, were stained with FITC-conjugated
monoclonal antibody against chlamydial lipopolysaccharide. C.
pneumoniae inclusion forming units (IFUs) were determined by
counting all microscope fields using a fluorescence microscope
(400x magnification).
C. pneumoniae VD4-ompA Genotyping
The VD4 region within ompA gene was selected as a target
for the typing of C. pneumoniae clinical isolate. A nested
PCR assay targeting a 366 bp fragment of the C. pneumoniae
ompA gene was performed as previously described by Bodetti
et al. (2002). The ompA PCR products were separated by gel
electrophoresis and excised from the gel using a Gel Extraction
Kit (Qiagen). Sense and anti-sense strands were sequenced with
an automated DNA sequencer using the BigDye Terminator
v1.1 Cycle sequencing Kit (Applied Biosystems). The sequence
obtained was analyzed using BLAST 2 (http://www.ncbi.nlm.
nih.gov/blast) and compared to C. pneumoniae VD4 sequences
available in the GenBank database including AR-39 and TW-
183 strains (GeneBank accession numbers AE017159, AE002161,
AE001363, BA000008, AF131889, AY426606, AY426607).
Growth Characteristics of C. pneumoniae
Clinical Isolate
HEp-2 and J774A.1 macrophage cells (ATCC TIB-67) (1 × 105
cells/well) were infected with C. pneumoniae clinical isolate or
AR-39 strain at a multiplicity of infection (MOI) of 1.0 by
centrifugation for 1 h at 1250 g at 37◦C. After the removal of
chlamydial inoculum, infected cells were incubated in DMEM
supplemented with 2% FCS and 1µg/mL cycloheximide at 37◦C
and 5% CO2 for up to 72 h.
At 24, 48, and 72 h post-infection, the infectious progeny and
genomic copy number of C. pneumoniae were detected.
The infectious progeny was determined by the development
of chlamydial inclusions after passage to fresh HEp-2 cell
monolayers. Briefly, cell monolayers were disrupted and passaged
to fresh HEp-2 cell monolayers grown on glass coverslips in 24
well-plates. After 72 h of incubation at 37◦C and 5% CO2, the
number of IFUs/mL was determined by counting all microscope
fields using a fluorescence microscope (400x magnification).
The genomic copy number of C. pneumoniae DNA was
detected by real-time PCR using the Primerdesign™ genesig R©
Kit as above described.
Foam Cell Analysis
J774A.1 macrophages (1.0× 105 cells/well) were infected with C.
pneumoniae clinical isolate and AR-39 strain at a MOI of 2.0 as
above described. Next, infected cells were washed with PBS and
cultured for 2 days in the presence or absence of human LDL
(100µg/mL; Sigma-Aldrich, St. Louis, MO). Foam cell formation
and intracellular cholesterol levels were determined as previously
described (Di Pietro et al., 2013b).
Cytokine Analysis
Interleukin (IL)-1β and IL-6 concentrations were measured
in gingival crevicular fluid samples by quantikine HS human
enzyme-linked immunosorbent assay (ELISA) according to
manufacturer’s instructions (R&D systems, Europe). The
detection limits for IL-1β and IL-6 were 0.14 and 0.11 pg/mL
respectively, and, if the cytokine concentrations were below the
limits of detection, a value of 0 was scored.
Statistical Analysis
Statistical analysis was performed by using SPSS 13.0 (SPSS
Inc. Chicago, IL, USA). Data were expressed as mean ±
standard deviation of three replicates from three independent
experiments. Comparison of means was performed by using a
two-tailed Student’s t-test. For the foam cell formation and the
cholesteryl ester to total cholesterol ratio, the Kruskal-Wallis
H test and the Mann-Whitney U test with the Bonferroni’s
correction were used. P ≤ 0.05 was considered statistically
significant.
RESULTS
C. pneumoniae Clinical Isolate
C. pneumoniae DNA was detected in gingival crevicular fluid
collected from diseased periodontal site by quantitative real-time
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FIGURE 1 | Immunohistological staining of cells from the gingival
crevicular fluid. Presence of C. pneumoniae in the diseased periodontal site
(A) and absence in the healthy site (B). The gingival crevicular fluid samples
were stained, and FITC-marked chlamydial inclusions (green) were visualized
by fluorescence microscope (400x magnification).
PCR targeting MOMP gene. As compared to the calibration
curve derived from serial dilutions of C. pneumoniae DNA,
the average quantitative-PCR cycle threshold values in gingival
crevicular fluid corresponded to the presence of 142,950 copies
of C. pneumoniae DNA per microliter of sample.
In addition, the gingival crevicular fluid from the diseased
periodontal site was positive to C. pneumoniae when subjected
to direct fluorescence assay as evidenced by the presence of
intracellular Chlamydia (Figure 1).
Conversely, no C. pneumoniae DNA, as well as chlamydial
inclusions, was detected in gingival crevicular fluid obtained from
healthy periodontal site.
Next, the crevicular gingival fluid sample positive to C.
pneumoniae was subjected to culture in HEp-2 cells. An average
of 50 chlamydial inclusions was detected in gingival crevicular
fluid after three growth cycles of 3 days. The presence of
C. pneumoniae in HEp-2 cell monolayers was confirmed by
real-time PCR assay targeting C. pneumoniaeMOMP gene.
Further characterization of clinical isolate was performed
via C. pneumoniae VD4-ompA genotyping. As a result of this
analysis, the VD4 segment of ompA gene sequence from C.
pneumoniae clinical isolate was found to be 99% identical to the
human C. pneumoniae AR-39 and TW-183 sequences.
C. pneumoniae DNA Detection in PBMCs
No C. pneumoniaeDNAwas detected in PBMCs from the patient
with chronic periodontitis, despite the quantitative real-time
PCR revealed the presence of C. pneumoniaeDNA in the gingival
crevicular fluid.
Growth Characteristics of C. pneumoniae
Clinical Isolate
The intracellular growth of C. pneumoniae clinical isolate
was first analyzed in HEp-2 epithelial cells. Specifically, the
infectious progeny as well as the genomic copy number of C.
pneumoniae were detected at 24, 48, and 72 h post-infection.
As shown in Figure 2A, C. pneumoniae clinical isolate and
AR-39 strain displayed a similar kinetic growth with increases
of IFUs of three orders of magnitude for both strains.
Although C. pneumoniae clinical isolate showed a higher growth
titer than AR-39 strain, there was no statistically significant
difference in the infectious progeny between the two strains
at 24, 48, and 72 h post-infection. No significant difference in
inclusion morphology and size was also observed between C.
pneumoniae clinical isolate and AR-39 strain (Figure 3). The
quantitative detection of MOMP gene of C. pneumoniae by real-
time PCR of infected HEp-2 cells further revealed a similar
intracellular growth of the clinical isolate to the AR-39 strain
(Figure 2B).
Next, we examined the intracellular growth of C. pneumoniae
clinical isolate in a macrophage cell line since the latter has been
widely used to investigate the aspects of chlamydial host cell
infection related to the atherosclerotic process. C. pneumoniae
clinical isolate did not replicate efficiently in macrophages as
evidenced by a low number of infectious EBs detected at 24, 48,
and 72 h post-infection as compared to that detected in HEp-
2 cells (P < 0.00001). Specifically, the number of infectious
EBs remained unaltered at 24 and 48 h while it increased
significantly at 72 h post-infection (P < 0.01). However, the
levels of infectious EBs produced by C. pneumoniae clinical
isolate were similar to those produced by the AR-39 strain
(Figure 4).
C. pneumoniae Clinical Isolate-induced
Foam Cell Formation
In order to evaluate the pro-atherogenic effects of the C.
pneumoniae strain isolated from the gingival crevicular fluid,
we determined the number of macrophage-derived foam cells
as well as the ratio of intracellular cholesteryl ester to total
cholesterol after 48 h incubation in the presence of LDL. A
Kruskal-Wallis H test showed a statistically significant difference
in the foam cell formation and the ratio of cholesteryl ester
to total cholesterol between the different groups [uninfected
macrophages, macrophages infected with C. pneumoniae clinical
isolate and macrophages infected with the AR-39 strain, χ2(2) =
15.16, P = 0.0005].
Compared to uninfected and LDL-treated macrophages, C.
pneumoniae clinical isolate significantly increased the number
of foam cells (6 vs. 45%; P = 0.0065). Moreover, a significant
difference in the number of foam cells between the C.
pneumoniae clinical isolate (45%) and the AR-39 strain (30%;
P= 0.0065) was observed (Figures 5, 6A). Lastly, C. pneumoniae
clinical isolate significantly increased the ratio of intracellular
cholesteryl ester to total cholesterol as compared to uninfected
LDL-treated macrophages (76 vs. 28%; P= 0.0065). A significant
difference in the ratio of intracellular cholesteryl ester to total
cholesterol between the C. pneumoniae clinical isolate (76%)
and the AR-39 strain (58%; P = 0.0065) was also found
(Figure 6B).
Cytokine Levels
IL-1β and IL-6 concentrations were significantly higher in the
diseased site (IL-1β: 2.1 ± 0.3 pg/µL; IL-6: 0.6 ± 0.08 pg/µL)
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FIGURE 2 | Comparative growth of C. pneumoniae clinical isolate and AR-39 strain in HEp-2 epithelial cells. HEp-2 cells were infected with C. pneumoniae
clinical isolate and AR-39 strain at a MOI of 1.0. At 24, 48, and 72 h post-infection, (A) infectious progeny and (B) genomic copy number of both strains were
assessed as described in Materials and Methods.
FIGURE 3 | Immunohistological staining of HEp-2 cell monolayers
infected with C. pneumoniae clinical isolate and AR-39 strain. HEp-2
cells were infected with (A) C. pneumoniae clinical isolate and (B) AR-39 strain
(MOI 1.0). After 72 h of incubation, HEp-2 cell monolayers were fixed, stained,
and FITC-marked chlamydial inclusions (green) were visualized by
fluorescence microscope (400x magnification).
than in the healthy periodontal site (IL-1β: 0.51 ± 0.08 pg/µL;
IL-6: 0.01 ± 0.004 pg/µL; IL-1β, P = 0.0009; IL-6, P <
0.0001).
DISCUSSION
The main result of our study is the isolation, for the first time,
of C. pneumoniae from the gingival crevicular fluid of a patient
with chronic periodontitis, suggesting that this microorganism
may harbor inside the oral cavity, acting as a reservoir of
the infection. Indeed, other intracellular microorganisms have
been detected in the gingival crevicular fluid, supporting the
hypothesis that this body fluid could be the intraoral source of
the pathogens (Maticic et al., 2001; Suzuki et al., 2005). This
may be explained by the characteristics of the gingival crevicular
fluid, an inflammatory exudate containing substances from the
host, as well as from supra- and sub-gingival located bacteria.
Inflammatory and immune cells that have infiltrated into the
periodontal tissues are also found in the gingival crevicular fluid
together with markers of inflammation, including cytokines and
interleukins (Rahnama et al., 2014; Atram et al., 2015).
The significant genomic copy number of C. pneumoniae,
detected in the gingival crevicular fluid, excludes the transient
oral colonization, and the isolation by culture of chlamydial
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FIGURE 4 | Comparative growth of C. pneumoniae clinical isolate and AR-39 strain in macrophage cell line. Macrophages were infected with C.
pneumoniae clinical isolate and AR-39 strain at a MOI of 1.0. At 24, 48, and 72 h post-infection, infectious progeny was assessed as described in Materials and
Methods.
FIGURE 5 | Atherogenic features of C. pneumoniae clinical isolate.
Macrophages were infected with C. pneumoniae clinical isolate (MOI 2.0) and
incubated in the (A) presence or (B) absence of LDL. After 48 h, the foam cells
were identified by using Oil-Red O staining. Micrograph images show Oil-Red
O stained macrophages with large amounts of intracellular lipid droplets.
infectious EBs, together with the evidence of intracellular
Chlamydia, confirms the presence of an active infection able
to contribute to periodontal tissue damage. Interestingly, the
detection of a high number of genomic copies paralleled by a
low number of infectious EBs suggests the presence of live C.
pneumoniae and chlamydial persistent forms that seem to be
involved in chronic inflammatory diseases (Hogan et al., 2004;
Kern et al., 2009). The low number of C. pneumoniae infectious
EBs and the high amount of chlamydial DNA may also be due to
the presence of dead bacteria.
The C. pneumoniae strain that we successfully isolated came
from a patient who was free, at the time of the specimen
collection, from any documented acute or chronic respiratory
and cardiovascular disease. However, we cannot rule out the
presence of asymptomatic atherosclerotic plaques, such as those
of early atherosclerosis, since the patient was at increased
risk for cardiovascular diseases. In fact, the estimated 10-year
cardiovascular risk according to the Framingham Heart Study
was 42%, whereas the normal 10-year risk was 15.1% (D’Agostino
et al., 2008).
We investigated the molecular and phenotypical
characteristics of the C. pneumoniae clinical isolate and we
compared them to the AR-39 strain, also known as TWAR as it
was isolated in Taiwan in a patient with pharyngitis (Kuo et al.,
1995) and whose association with atherosclerosis has been well
documented (Watson and Alp, 2008; Campbell and Rosenfeld,
2015). In our study, a 99% similarity was found in the sequence
of the VD4 ompA gene between C. pneumoniae clinical isolate
and the AR-39 strain. A high molecular similarity between the
two strains is not surprising, since the genomic data from all
the sequenced C. pneumoniae strains showed a marked genetic
conservation (Rattei et al., 2007).
Notably, the phenotypical characteristics of the two strains
were also similar. In fact, a comparable growth kinetic in
epithelial cells of the C. pneumoniae clinical isolate as compared
to the AR-39 strain was observed, as evidenced by the infectious
progeny and by the number of genomic copies. The similarity of
the phenotypical characteristics between the two strains resulted
also from a comparable size and morphology of chlamydial
inclusions.
Further analysis of the phenotypical features of the C.
pneumoniae clinical isolate revealed, similarly to the AR-39
strain, its ability to survive and mainly generate infectious
EBs within macrophages. The production of infectious EBs
in macrophages is of great pathophysiological significance,
since it supports the potential ability of C. pneumoniae isolate
to systematically disseminate through monocytes-macrophages
and translocate to the vascular tissue, contributing to the
atherosclerotic process. In this regard, several studies have
provided the evidence that C. pneumoniae disseminates through
the PBMCs to the vasculature and to other extra-pulmonary sites
(Gieffers et al., 2004; Little et al., 2005; Rupp et al., 2005; Sessa
et al., 2007; Watson and Alp, 2008; Di Pietro et al., 2013c).
In our study, C. pneumoniae DNA was not detected in the
PBMCs of the patient with chronic periodontitis. However, we
cannot rule out the potential dissemination of C. pneumoniae
clinical strain from the oral cavity to the vasculature. Indeed,
the low amount of chlamydial infectious EBs isolated from
the gingival crevicular fluid may not be enough to allow
the translocation of C. pneumoniae into PBMCs. The lack of
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FIGURE 6 | Comparison of the atherogenic properties between C. pneumoniae clinical isolate and AR-39 strain. The (A) foam cell formation and (B) the
ratio of intracellular cholesteryl ester to total cholesterol in macrophages infected with C. pneumoniae clinical isolate and AR-39 strain, in the presence or absence of
LDL.
chlamydial DNA in PBMCs may also be due to the putative
presence of chlamydial persistent forms in the gingival crevicular
fluid, that are not-infectious and, thus, unable to translocate
into the systemic circulation. Furthermore, as recently suggested
by Zafiratos et al. (2015), only chlamydial antigens may be
carried by PBMCs to the vasculature where they become
targets of attack by antigen-specific CD8+ T cells, exacerbating
the atherosclerotic process. Therefore, monitoring the patient
over the time will be needed to demonstrate C. pneumoniae
dissemination.
Of particular clinical relevance is the foam cell formation
following the infection of macrophages, suggesting the potential
atherogenic features of C. pneumoniae clinical strain. The
enhanced foam cell accumulation is considered a key event
in the initiation of atherosclerotic plaque development. In this
regard, C. pneumoniae infection of macrophages has been shown
to trigger the oxidation and accumulation of LDL through
the release of reactive oxygen species, the increased expression
of lipoprotein lipase via chlamydial lipopolysaccharide and
the dysregulation of receptors involved in cholesterol eﬄux
via nuclear receptor peroxisome proliferator-activated receptor-
γ (Di Pietro et al., 2013a; Cheng et al., 2014; Zhao et al.,
2014).
The high similarity of C. pneumoniae clinical isolate with
the AR-39 strain, usually associated to atherosclerosis (Watson
and Alp, 2008; Campbell and Rosenfeld, 2015), emphasizes
the importance of the isolation of a potential atherogenic
C. pneumoniae strain from the oral cavity although further
investigations are needed to prove this evidence.
In our study, a further interesting finding is the possible
involvement of C. pneumoniae in the local chronic
inflammation, as suggested by the increased levels of IL-
1β and IL-6 detected in the gingival crevicular fluid of the
patient with chronic periodontitis. Both these cytokines
are major players in the periodontal inflammatory process
underlying chronic periodontitis (Faizuddin et al., 2003;
Ebersole et al., 2014). Thus, we can hypothesize that, upon
C. pneumoniae infection, fibroblasts, epithelial cells and
macrophages, typically present in the periodontium, may
secrete pro-inflammatory cytokines involved in the disease
progression and the subsequent destruction of the periodontal
tissue.
In conclusion, the isolation of a potential atherogenic strain
of C. pneumoniae from the gingival crevicular fluid of a patient
with chronic periodontitis provides the basis to make some
compelling hypothesis. First, C. pneumoniae may take part to
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the initiation and/or the development of chronic periodontitis
and, perhaps, contribute to the local chronic inflammatory
state. Second, C. pneumoniae, similarly to other periodontal
pathogens, under favorable conditions such as the destruction
of the peridontium, that occurs during periodontitis, may
systematically disseminate and localize in the vascular wall,
increasing the risk for cardiovascular diseases. However, the data
presented in our paper must be interpreted with caution until
validated by additional studies in order to clarify the involvement
of C. pneumoniae in chronic periodontitis as a risk factor for
cardiovascular diseases.
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